1. Home
  2. NRXP vs SMTK Comparison

NRXP vs SMTK Comparison

Compare NRXP & SMTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • SMTK
  • Stock Information
  • Founded
  • NRXP 2015
  • SMTK 2009
  • Country
  • NRXP United States
  • SMTK United Kingdom
  • Employees
  • NRXP N/A
  • SMTK N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • SMTK
  • Sector
  • NRXP Health Care
  • SMTK
  • Exchange
  • NRXP Nasdaq
  • SMTK NYSE
  • Market Cap
  • NRXP 48.5M
  • SMTK 13.3M
  • IPO Year
  • NRXP N/A
  • SMTK N/A
  • Fundamental
  • Price
  • NRXP $4.01
  • SMTK $3.72
  • Analyst Decision
  • NRXP Strong Buy
  • SMTK
  • Analyst Count
  • NRXP 3
  • SMTK 0
  • Target Price
  • NRXP $31.67
  • SMTK N/A
  • AVG Volume (30 Days)
  • NRXP 2.8M
  • SMTK 109.9K
  • Earning Date
  • NRXP 11-14-2024
  • SMTK 02-12-2025
  • Dividend Yield
  • NRXP N/A
  • SMTK N/A
  • EPS Growth
  • NRXP N/A
  • SMTK N/A
  • EPS
  • NRXP N/A
  • SMTK N/A
  • Revenue
  • NRXP N/A
  • SMTK $40,000.00
  • Revenue This Year
  • NRXP N/A
  • SMTK N/A
  • Revenue Next Year
  • NRXP N/A
  • SMTK N/A
  • P/E Ratio
  • NRXP N/A
  • SMTK N/A
  • Revenue Growth
  • NRXP N/A
  • SMTK 471.43
  • 52 Week Low
  • NRXP $1.10
  • SMTK $2.01
  • 52 Week High
  • NRXP $7.33
  • SMTK $13.00
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 61.48
  • SMTK N/A
  • Support Level
  • NRXP $3.20
  • SMTK N/A
  • Resistance Level
  • NRXP $6.01
  • SMTK N/A
  • Average True Range (ATR)
  • NRXP 0.95
  • SMTK 0.00
  • MACD
  • NRXP 0.11
  • SMTK 0.00
  • Stochastic Oscillator
  • NRXP 56.52
  • SMTK 0.00

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About SMTK SMARTKEM INC

SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in a number of applications including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.

Share on Social Networks: